Skip to main content

Table 2 The baseline characteristics of patient group

From: High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

Nr.

Probands age at diagnosis (years)

Primary cancer site

Morphological subtype

Breast cancersubtype

Tumor grade

Family history

1

54

Breast

Ductal

Luminal

missing

Mother and maternal aunt – breast cancer age 60; daughter - polycytemia vera age15, brother – melanoma age 60

2

40

Breast

Ductal

Triple-negative*

G3

Mother - Breast and ovarian cancer age 40

3

33 and 38

Left Breast/ Right Breast

Ductal/ Ductal

Triple-negative/ Luminal

G3/G3

Paternal grandmother - unknown primary gynecological cancer age 50

4

63

Breast and Ovaries

Ductal

Triple-negative

G2

Mother with breast cancer age 55; sister - ovarian cancer age 59

5

37

Ovaries

NA

NA

NA

Mother - breast cancer age 64

6

58

Breast

Lobular

Luminal

G2

Mother and maternal aunt – breast cancer age > 60

7

43

Breast

Ductal

Triple-negative

G3

No

8

42

Breast

Ductal/Medullary

Triple-negative

G2

Mother - breast cancer age 60

9

50

Breast

Ductal

Triple-negative

G3

Mother - breast cancer age 52

10

35

Breast

Ductal

Triple-negative

G3

Mother - breast cancer age 46

11

52

Breast

Ductal

Luminal B HER2 positive

G2

Mother and maternal aunt – breast cancer age > 50

12

41

Breast

Ductal

HER2 positive

G3

No

13

53

Breast

Ductal

Triple-negative

missing

No

14

36

Breast

Ductal

Luminal

missing

No

15

53

Breast

Ductal

Luminal

missing

Mother and maternal grandmother – breast cancer age > 60 years

16

40

Breast

Ductal

Luminal B HER2 positive

missing

No